LONDON DAILY ARCHIVE

Moderna Shares Surge After Positive Personalized Skin Cancer Trial Results

Moderna shares nearly trebled after the biotechnology company reported successful clinical results for personalized mRNA treatments targeting aggressive skin cancer, adding billions of dollars to its market value and drawing investor attention to the drugmaker’s pipeline.

20 August 2026 · 08:42 UTC